Robert Nelsen's Net Worth

$3.31 Billion

Estimate Recalculated Feb 23, 2024 05:13PM EST

Who is Robert Nelsen?

Robert Nelsen has an estimated net worth of $3.31 Billion. This is based on reported shares across multiple companies, which include PHASERX, INC., Neumora Therapeutics, Inc., ADESTO TECHNOLOGIES Corp, IMPINJ INC, VBI VACCINES INC., NeurogesX Inc, Receptos, Inc., Gossamer Bio, Inc., Scholar Rock Holding Corp, Erasca, Inc., Pulmatrix, Inc., Verve Therapeutics, Inc., bluebird bio, Inc., Metacrine, Inc., Unity Biotechnology, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., Homology Medicines, Inc., Achaogen Inc, Trubion Pharmaceuticals, Inc, Beam Therapeutics Inc., Syros Pharmaceuticals, Inc., XTERA COMMUNICATIONS, INC., CELEBRATE EXPRESS, INC., Sana Biotechnology, Inc., KYTHERA BIOPHARMACEUTICALS INC, ALNYLAM PHARMACEUTICALS INC, Lyell Immunopharma, Inc., AGIOS PHARMACEUTICALS INC, DA32 Life Science Tech Acquisition Corp., 908 Devices Inc., Karuna Therapeutics, Inc., Quanterix Corp, Revolution Healthcare Acquisition Corp., Denali Therapeutics Inc., FATE THERAPEUTICS INC, Twist Bioscience Corp, Sage Therapeutics, Inc., Vir Biotechnology, Inc., Bellerophon Therapeutics, Inc., XCYTE THERAPIES INC, Juno Therapeutics, Inc., Prime Medicine, Inc., ILLUMINA INC, and ADOLOR CORP.

SEC CIK

Robert Nelsen's CIK is 0001219042

Past Insider Trading and Trends

2021 was Robert Nelsen's most active year for acquiring shares with 46 total transactions. Robert Nelsen's most active month to acquire stocks was the month of May. 2021 was Robert Nelsen's most active year for disposing of shares, totalling 62 transactions. Robert Nelsen's most active month to dispose stocks was the month of September. 2023 saw Robert Nelsen paying a total of $31,430,024.08 for 19,674,447 shares, this is the most they've acquired in one year. In 2018 Robert Nelsen cashed out on 37,536,215 shares for a total of $924,384,696.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PHASERX, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.62%
319.94K
$2.51
$4,993,199.41
2.85M
May 23
Form 3/A
0
0
Form 3
0
0
No matching records found

Neumora Therapeutics, Inc. (NMRA) Snapshot price: $16.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+102.76%
1.88M
3.71M
Dec 8
Form 4
+0.85%
35.01K
$11.77
$412,139.61
4.13M
Nov 13 - Nov 14
Form 4
+3.55%
140.6K
$10.98
$1,543,563.42
4.1M
Nov 8 - Nov 10
Form 4
+2.48%
95.69K
$11.49
$1,099,944.70
3.96M
Nov 3 - Nov 7
Form 4
+2.02%
76.51K
$13.68
$1,046,848.16
3.86M
Sep 28 - Sep 29
Form 4
+1.57%
58.5K
$11.97
$700,464.24
3.78M
Sep 26 - Sep 27
Form 4
+2.78%
100.74K
$11.19
$1,127,063.95
3.72M
Sep 22 - Sep 25
Form 4
+178.19%
18.92M
$17.00
29.55M
Sep 19
Form 3
0
0
No matching records found

ADESTO TECHNOLOGIES Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+469.13%
1.88M
2.28M
Oct 30
Form 4
400K
$5.00
$2,000,000.00
400K
Oct 26
Form 3
0
0
No matching records found

IMPINJ INC (PI) Snapshot price: $106.565

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
1.37M
$10.73
$204.50
1.37M
Jul 26
Form 4
1.36M
$11.66
$68.32
1.36M
Jul 26
Form 3
0
0
No matching records found

VBI VACCINES INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+19.13%
650K
$2.10
$1,365,000.00
4.05M
Aug 13
Form 3/A
0
0
Form 3
0
0
No matching records found